White Paper — Sponsored Content

Exploring the Myth of Inert Excipients

Exploring the Myth of Inert Excipients

API Stability in Solid Dose Formulation: Exploring the Myth of Inert Excipients

Stable active pharmaceutical ingredients (APIs) represent a critical success factor for drug formulation. This white paper examines the potential impact of poor API stability in solid dose drug development, explores the causes of instability and explains how excipients can help in creating stable formulations using case studies to demonstrate the excipients’ effectiveness. 

Download White Paper


To download this white paper, complete the form below. Once submitted, you will receive a link via the email you provided to download the white paper.

Name
Company Type
Address

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.